Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma

Background. Cutaneous malignant melanoma (CMM) is a heterogeneous disease, acknowledged for its lack of predictability regarding clinical evolution. In order to appreciate a patient's individual prognosis, an attempt is made to find new tumor markers that parallel the disease progression. Objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandru, Angela, Panaitescu, Eugenia, Voinea, Silviu, Bolovan, Madalina, Stanciu, Adina, Cinca, Sabin, Blidaru, Alexandru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090457/
https://www.ncbi.nlm.nih.gov/pubmed/25045539
http://dx.doi.org/10.1155/2014/843214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090457/
https://www.ncbi.nlm.nih.gov/pubmed/25045539
http://dx.doi.org/10.1155/2014/843214

Ejemplares similares